Chronic kidney disease (CKD) is a major global health issue – affecting an estimated 1 in 10 people – yet it is frequently overlooked on health agendas worldwide. In its early stages, CKD is often asymptomatic, and many individuals are unaware that they have CKD until the disease has progressed to later stages, where it becomes harder and more costly to treat – with patients facing the prospect of dialysis or kidney transplant. This makes early CKD detection critical to improving patient outcomes and reducing the growing health and economic burden of CKD worldwide. Recognising this, the World Kidney Day campaign this year is centred around the theme: “Detect early, protect kidney health.”
Rare Disease Day presents a time to reflect on the progress made in understanding and addressing the unique challenges that rare diseases bring – and the hurdles that remain. Over the past year, several significant developments have shaped the rare disease landscape, from new regulatory policies and technological advancements to major advocacy efforts.
Awareness of the vast impact of rare diseases, which affect approximately 300 million people globally (1), has significantly increased over the years, leading to increased funding and investment in rare disease research and therapy development. Although more than half of the novel drug approvals by the FDA’s Center for Drug Evaluation and Research last […]
New blog published this week by Evidence & Policy co-authored by our COO and Co-Founder Laura Webber. The blog builds off research by Laura and collaborators at Lancaster University and the University of York on the health impacts universal basic income (UBI) could have. The role of UBI has come to the fore during the […]
Yesterday saw the launch of the National Strategy to meet the government’s stated mission of “five extra healthy years by 2035”. The key challenge this initiative aims to address is that, whilst we are all living longer, too many of these years are just extra years of bad health. There are also continued, significant health […]
The term “20/20 vision” informally denotes perfect eyesight. So, moving into the year 2020 it is an apt metaphor for our goal, which is to help improve global population health through better decision-making. Our forecasting methodology – based on a microsimulation model – integrates health, economic and population data from multiple sources as a baseline […]
In the weeks before his election Boris Johnson called for a review and potential roll back of ‘sin taxes’ which bemused experts, including the public health community. He stated that “once we leave the EU on 31 October, we will have a historic opportunity to change the way politics is done in this country. A […]
How do you answer questions about the health of the population? How do you test ideas for policy and intervention change when the option for an experiment or randomized control trial does not exist? High level, national public health policies can have a significant impact on shaping and creating the environments – physical, food, healthcare, […]
Two news stories dominated the headlines this week – Cancer Research UK (CRUK) rolling out a new campaign linked with their findings that obesity is now the leading risk factor for four cancers and Conservative leadership candidate Boris Johnson calling for a review and potential roll-back of ‘sin taxes’, in particular those measures designed to alter consumer food environments.
When you need a future-facing decision engine for big, real world population health questions, we are the people to turn to.
Solutions